Added therapeutic benefit regarding ESMO-MCBS and the French health technology assessment of drugs granted early access program.
In: Annals of Oncology, Jg. 33 (2022-05-01), Heft 5, S. 561-563
Online
academicJournal
Zugriff:
Titel: |
Added therapeutic benefit regarding ESMO-MCBS and the French health technology assessment of drugs granted early access program.
|
---|---|
Autor/in / Beteiligte Person: | Pham, F.Y. V. ; Jacquet, E. ; Monard, A. ; Brunel, L. ; Blay, J. Y. ; Albin, N. |
Link: | |
Zeitschrift: | Annals of Oncology, Jg. 33 (2022-05-01), Heft 5, S. 561-563 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 0923-7534 (print) |
DOI: | 10.1016/j.annonc.2022.02.002 |
Schlagwort: |
|
Sonstiges: |
|